Overview
- 10 public-safe observations are available for this inspection.
- 5 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
18 May 2017
21 CFR 820.30(g)
Design Validation - Risk analysis not performed/inadequate
Cited by Benjamin J Dastoli
18 May 2017
21 CFR 820.30(g)
Design Validation - Risk analysis not performed/inadequate
Cited by Benjamin J Dastoli
18 May 2017
21 CFR 820.40
Procedures not adequately established or maintained
Cited by Benjamin J Dastoli
Inspected site
PLPeter Lazic GmbhTuttlingen, Germany
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 820.100(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.30(g) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.40 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.50(a)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.90(a) | Cited across public-safe Form 483 observations | 2x |
Full 483 report
Get the verbatim text of all 10 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere